St. Albans, United Kingdom

James Charles Wickens


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James Charles Wickens

Introduction

James Charles Wickens is an accomplished inventor based in St. Albans, England. With a notable contribution to the field of pharmaceuticals, he has made significant strides in developing new compounds that have therapeutic applications. With a rich background in research and development, Wickens has showcased his ingenuity through his patent that focuses on benzofuran derivatives.

Latest Patents

Wickens holds a patent titled "7-Substituted Benzofuran Derivatives." This patent involves the discovery of new benzofuran derivatives along with a process for their preparation. The significance of these compounds lies in their potential use as β-adrenergic blocking agents, which can play a crucial role in treating various medical conditions.

Career Highlights

James Charles Wickens is currently affiliated with Hoffmann-La Roche Inc., a leading global healthcare company known for its innovative medicines. His work at this esteemed organization reflects his commitment to advancing pharmaceutical research and his passion for developing vital health solutions.

Collaborations

Throughout his professional journey, Wickens has collaborated with esteemed colleagues, including Graham Alwyn Fothergill and John M. Osbond. These collaborations represent a fusion of expertise and innovation, contributing to the rich tapestry of research at Hoffmann-La Roche Inc.

Conclusion

James Charles Wickens exemplifies the spirit of innovation in the pharmaceutical industry. With his patent on benzofuran derivatives, he continues to pave the way for new treatments and advancements in healthcare. His dedication and collaborations highlight the importance of teamwork in achieving impactful inventions that benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…